How Psychedelics Alter Brain Perception: A Journey from Ancient Rituals to Modern Neuroscience

Psychedelics, substances once relegated to the fringes of culture, are now the subject of intense scientific scrutiny. Recent research, including a new study in mice, is shedding light on how these compounds impact brain function, offering potential insights into the treatment of mental health conditions. This exploration builds upon a long history of psychedelic use, dating back thousands of years in indigenous cultures.

Ancient Roots of Psychedelic Use

The use of psychedelic substances is not a modern phenomenon. Archaeological evidence reveals a rich history of their ritualistic and medicinal applications. The Aztecs of Mexico utilized psilocybin mushrooms for healing purposes, while Andean cultures consumed mescaline-rich San Pedro cacti millennia ago. A ritual bundle discovered in a Bolivian cave contained traces of DMT, a potent hallucinogen, and 5,000-year-old peyote buttons were found in Texas, demonstrating the deep-rooted connection between humans and these substances. The Conversation

The Modern Era of Psychedelic Research

The modern scientific investigation of psychedelics began in 1938 with the synthesis of LSD by Swiss chemist Albert Hofmann. In the 1970s and 80s, researchers identified the 5-HT2A serotonin receptor as a key target for these drugs, finding that activation of this receptor could trigger hallucinations. The Conversation Today, scientists are exploring whether the therapeutic benefits of psychedelics stem from the psychedelic experience itself or from their ability to promote neuroplasticity – the brain’s capacity to rewire and form new connections.

New Insights from Mouse Studies

A recent study using mice has provided valuable clues about how psychedelics alter perception. Researchers engineered mice with brain cells that glow when active, allowing them to monitor brain activity in real-time. They observed that when a psychedelic drug activating the 5-HT2A serotonin receptor was administered, the brain’s response to visual stimuli was dampened, while connections with memory areas were strengthened. This resulted in the brain “filling in” missing visuals from memory, effectively overriding external reality with internal imagery. The Conversation

The Role of Brain Oscillations and the Retrosplenial Cortex

The study pinpointed specific changes in brain activity. Before the drug, the visual cortex produced 5-Hz brain oscillations. After the psychedelic was administered, these oscillations intensified and synchronized with the retrosplenial cortex, a brain region involved in memory encoding, storage, and retrieval. This synchronization, occurring with a delay of approximately 18 milliseconds, suggests a traveling wave of activity connecting the two regions. The researchers described this state as remarkably similar to partial dreaming, where internal imagery dominates perception. The Conversation

Psilocybin and its Varieties

Psilocybin mushrooms, commonly known as magic mushrooms or shrooms, contain psilocybin, a prodrug that converts to the psychedelic psilocin in the body. Wikipedia The most potent species belong to the Psilocybe genus, including P. Azurescens, P. Semilanceata, and P. Cyanescens, but psilocybin is also found in other genera like Panaeolus, Inocybe, Pluteus, Gymnopilus, and Pholiotina. Wikipedia

Future Directions: Non-Hallucinogenic Therapeutics

While these findings offer valuable insights, researchers acknowledge limitations. The study was conducted on mice, and it remains unclear whether the observed phenomena translate directly to human experiences. However, the research could pave the way for the development of non-hallucinogenic drugs that enhance neuroplasticity and offer therapeutic benefits for mental health conditions, potentially without the side effects of traditional psychedelic experiences. The Conversation